BioSpace News Archive

Genetown

Dicerna Announces Proposed Public Offering of Common Stock

The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

December 13, 2017
·
4 min read
Business

Tetra Bio-Pharma Reinforces Its Development Program by Signing Research & Development Agreement With Constance Therapeutics and Receiving Financial Support From NSERC

In collaboration, Tetra and Constance Therapeutics now aim to define the therapeutic mechanism and demonstrate efficacy of these cannabis extracts in the treatment of human cancers.

December 13, 2017
·
6 min read
Business

Helix BioPharma Corp. Announces Fiscal First Quarter 2018 Results

The Company recorded a net loss and total comprehensive loss of $2,303,000 ($0.02 loss per common share) and $3,287,000 ($0.04 loss per common share) for the three-month periods ended October 31, 2017 and 2016, respectively.

December 13, 2017
·
14 min read
Business

Bristol-Myers Forks Over $40M Upfront for Another One of Ono Pharma’s Cancer Prospects

The companies will also collaborate on discovery efforts to identify additional compounds from Ono’s PGE2 receptor antagonist programs.

December 13, 2017
·
6 min read